Open AccessTranscervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE): Study Protocol and Preliminary Results
Author(s) -
Ladina Christoffel,
Thomas Römer,
Sven Schiermeier
Publication year - 2021
Publication title -
medical devices
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.482
H-Index - 30
ISSN - 1179-1470
DOI - 10.2147/mder.s301166
Subject(s) - medicine , uterine fibroids , adverse effect , ablation , quality of life (healthcare) , endometrial ablation , obstetrics , incidence (geometry) , radiofrequency ablation , gynecology , physics , nursing , optics
Transcervical fibroid ablation (TFA) is a minimally invasive, effective treatment of symptomatic uterine fibroids that utilizes intrauterine ultrasound for imaging and radiofrequency energy for ablation. Outcomes reported with TFA have been positive, with significant reductions in fibroid volume, improvements in symptom severity and health-related quality of life, and low complication and surgical reintervention rates. The SAGE registry characterizes the long-term (5-year) outcomes of TFA when used to treat symptomatic uterine fibroids in real-world usage.